Doug J. Jolly
- Molecular Biology
- Genetics top 5%
- Pulmonary and Respiratory Medicine
- Infectious Diseases top 10%
- Epidemiology
- Co-authors
- T FriedmannKeith D. LunnenS F WolfGuoshun WangPaul B. McCrayBeverly L. DavidsonJoseph ZabnerMordechai Bodner
- Topics
- Virus-based gene therapy research (14 papers)CRISPR and Genetic Engineering (5 papers)CAR-T cell therapy research (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Doug J. Jolly
23 papers receiving 852 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 558
- Genetics 541
- Pulmonary and Respiratory Medicine 154
- Infectious Diseases 126
- Epidemiology 125
Countries citing papers authored by Doug J. Jolly
This map shows the geographic impact of Doug J. Jolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug J. Jolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug J. Jolly more than expected).
Fields of papers citing papers by Doug J. Jolly
This network shows the impact of papers produced by Doug J. Jolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug J. Jolly. The network helps show where Doug J. Jolly may publish in the future.
Co-authorship network of co-authors of Doug J. Jolly
This figure shows the co-authorship network connecting the top 25 collaborators of Doug J. Jolly. A scholar is included among the top collaborators of Doug J. Jolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug J. Jolly. Doug J. Jolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 28 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 18 | |
| 6 | 26 | |
| 7 | 23 | |
| 8 | 5 | |
| 9 | 123 | |
| 10 | 23 | |
| 11 | 134 | |
| 12 | 11 | |
| 13 | 20 | |
| 14 | 5 | |
| 15 | Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritis. | 25 |
| 16 | 31 | |
| 17 | Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon. | 22 |
| 18 | Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. | 27 |
| 19 | 11 | |
| 20 | 4 |
About Doug J. Jolly
Doug J. Jolly is a scholar working on Virology, Genetics and Biotechnology, having authored 24 papers that have together received 895 indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CRISPR and Genetic Engineering (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Genetics (541 citations), Molecular Biology (558 citations) and Infectious Diseases (126 citations). Doug J. Jolly has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include T Friedmann, Keith D. Lunnen, S F Wolf, Guoshun Wang, Paul B. McCray, Beverly L. Davidson, Joseph Zabner, Mordechai Bodner, Vladimir Slepushkin and Helmuth H. G. van Es. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.